» Articles » PMID: 24925692

Health Assessment Questionnaire Disability Progression in Early Rheumatoid Arthritis: Systematic Review and Analysis of Two Inception Cohorts

Overview
Specialty Rheumatology
Date 2014 Jun 14
PMID 24925692
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The Health Assessment Questionnaire is widely used for patients with inflammatory polyarthritis (IP) and its subset, rheumatoid arthritis (RA). In this study, we evaluated the progression of HAQ scores in RA (i) by systematically reviewing the published literature on the methods used to assess changes in functional disability over time and (ii) to study in detail HAQ progression in two large prospective observational studies from the UK.

Methods: Data from two large inception cohorts, ERAS and NOAR, were studied to determine trajectories of HAQ progression over time by applying latent class growth models (LCGMs) to each dataset separately. Age, sex, baseline DAS28, symptom duration, rheumatoid factor, fulfilment of the 1987 ACR criteria and socio-economic status (SES) were included as potential predictors of HAQ trajectory subgroup membership.

Results: The literature search identified 49 studies showing that HAQ progression has mainly been based on average changes in the total study population. In the HAQ progression study, a LCGM with four HAQ trajectory subgroups was selected as providing the best fit in both cohorts. In both the cohorts, older age, female sex, longer symptom duration, fulfilment of the 1987 ACR criteria, higher DAS28 and lower SES were associated with increased likelihood of membership of subgroups with worse HAQ progression.

Conclusion: Four distinct HAQ trajectory subgroups were derived from the ERAS and NOAR cohorts. The fact that the subgroups identified were nearly identical supports their validity. Identifying distinct groups of patients who are at risk of poor functional outcome may help to target therapy to those who are most likely to benefit.

Citing Articles

Current and Future Challenges for Rehabilitation for Inflammatory Arthritis.

Moe R, Vliet Vlieland T J Clin Med. 2024; 13(6).

PMID: 38542031 PMC: 10971004. DOI: 10.3390/jcm13061808.


Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis.

Bertsias A, Flouri I, Repa A, Avgoustidis N, Kalogiannaki E, Pitsigavdaki S RMD Open. 2024; 10(1).

PMID: 38242549 PMC: 10806522. DOI: 10.1136/rmdopen-2023-003808.


Prevalence and Predictors of Remission and Sustained Remission in Patients with Rheumatoid Arthritis from the United Arab Emirates: A Two-Year Prospective Study.

Al-Saleh J, Almarzooqi A, Negm A Open Access Rheumatol. 2023; 15:51-63.

PMID: 37192954 PMC: 10183195. DOI: 10.2147/OARRR.S408894.


Influence of Social Support, Financial Status, and Lifestyle on the Disparity Between Inflammation and Disability in Rheumatoid Arthritis.

Gwinnutt J, Norton S, Hyrich K, Lunt M, Combe B, Rincheval N Arthritis Care Res (Hoboken). 2022; 75(5):1026-1035.

PMID: 36576238 PMC: 10952173. DOI: 10.1002/acr.24996.


Inflammatory profile of incident cases of late-onset compared with young-onset rheumatoid arthritis: A nested cohort study.

Mena-Vazquez N, Lisbona-Montanez J, Redondo-Rodriguez R, Mucientes A, Manrique-Arija S, Rioja J Front Med (Lausanne). 2022; 9:1016159.

PMID: 36425102 PMC: 9679221. DOI: 10.3389/fmed.2022.1016159.


References
1.
Michaud K, Wallenstein G, Wolfe F . Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients. Arthritis Care Res (Hoboken). 2010; 63(3):366-72. PMC: 3047593. DOI: 10.1002/acr.20405. View

2.
Proudman S, Keen H, Stamp L, Lee A, Goldblatt F, Ayres O . Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Semin Arthritis Rheum. 2007; 37(2):99-111. DOI: 10.1016/j.semarthrit.2007.02.001. View

3.
Bombardier C, Barbieri M, Parthan A, Zack D, Walker V, Macarios D . The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review. Ann Rheum Dis. 2011; 71(6):836-44. DOI: 10.1136/annrheumdis-2011-200343. View

4.
Wolfe F, Michaud K . The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study. Arthritis Res Ther. 2010; 12(2):R35. PMC: 2888182. DOI: 10.1186/ar2944. View

5.
Gonzalez-Alvaro I, Descalzo M, Carmona L . Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort. Arthritis Res Ther. 2008; 10(6):R138. PMC: 2656242. DOI: 10.1186/ar2561. View